For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The closing price of Immunovant Inc (NASDAQ: IMVT) was $28.80 for the day, up 0.66% from the previous closing price of $28.61. In other words, the price has increased by $0.66 from its previous closing price. On the day, 0.67 million shares were traded. IMVT stock price reached its highest trading level at $29.54 during the session, while it also had its lowest trading level at $28.4.
Ratios:
Our analysis of IMVT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 22.14 and its Current Ratio is at 22.14. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on March 28, 2024, initiated with a Outperform rating and assigned the stock a target price of $50.
On March 13, 2024, Goldman started tracking the stock assigning a Buy rating and target price of $50.
On February 20, 2024, JP Morgan started tracking the stock assigning a Overweight rating and target price of $51.JP Morgan initiated its Overweight rating on February 20, 2024, with a $51 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 17 ’24 when Salzmann Peter sold 34,079 shares for $29.06 per share. The transaction valued at 990,269 led to the insider holds 1,052,879 shares of the business.
Barnett Eva Renee sold 12,253 shares of IMVT for $356,049 on Apr 17 ’24. The Chief Financial Officer now owns 359,456 shares after completing the transaction at $29.06 per share. On Apr 17 ’24, another insider, Butchko Julia G., who serves as the Chief Development Officer of the company, sold 10,115 shares for $29.06 each. As a result, the insider received 293,923 and left with 451,627 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMVT now has a Market Capitalization of 4184438016 and an Enterprise Value of 3493806592.
Stock Price History:
Over the past 52 weeks, IMVT has reached a high of $45.58, while it has fallen to a 52-week low of $15.39. The 50-Day Moving Average of the stock is -12.09%, while the 200-Day Moving Average is calculated to be -10.06%.
Shares Statistics:
IMVT traded an average of 1.15M shares per day over the past three months and 1125620 shares per day over the past ten days. A total of 130.33M shares are outstanding, with a floating share count of 60.46M. Insiders hold about 58.39% of the company’s shares, while institutions hold 46.30% stake in the company. Shares short for IMVT as of 1711584000 were 9019835 with a Short Ratio of 7.82, compared to 1709164800 on 8682388. Therefore, it implies a Short% of Shares Outstanding of 9019835 and a Short% of Float of 12.9.
